While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker …
Endogena Therapeutics, a biotech company that focuses on the first-in-class endogenous regenerative medicines, just announced treating the first patient with …
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …
Because of endogenous properties, extracellular vesicles (EVs) have shown impressive potential as remedial modalities; nevertheless, more bioengineering refinement is expected …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.